Adverse effects of fluoroquinolones

Results: 87



#Item
51Microsoft Word - press release I…AL[removed]doc

Microsoft Word - press release I…AL[removed]doc

Add to Reading List

Source URL: www.santeninc.com

Language: English - Date: 2013-08-06 15:12:38
52NDA[removed]S-070, NDA[removed]S-044, NDA[removed]S-051 NDA[removed]S-028, NDA[removed]S-025 Page 6 MEDICATION GUIDE

NDA[removed]S-070, NDA[removed]S-044, NDA[removed]S-051 NDA[removed]S-028, NDA[removed]S-025 Page 6 MEDICATION GUIDE

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2009-05-14 13:47:20
53HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use AVELOX safely and effectively. See full prescribing information for AVELOX.  -------------------------------CONTRAIN

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use AVELOX safely and effectively. See full prescribing information for AVELOX. -------------------------------CONTRAIN

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2013-08-15 17:45:24
54NDA[removed]S-006 FDA Approved Labeling dated[removed]Page 1 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use POTIGA safely and effectively. See full prescribing i

NDA[removed]S-006 FDA Approved Labeling dated[removed]Page 1 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use POTIGA safely and effectively. See full prescribing i

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2013-09-09 16:09:35
55TABLETS  NOROXIN® (NORFLOXACIN) WARNING:

TABLETS NOROXIN® (NORFLOXACIN) WARNING:

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2013-08-15 17:45:22
56GILENYA® (fingolimod) capsules

GILENYA® (fingolimod) capsules

Add to Reading List

Source URL: www.fda.gov

Language: English
57FDA Drug Safety Communication: Anti-seizure drug Potiga (ezogabine) linked to retinal abnormalities and blue skin discoloration Safety Announcement[removed]The U.S. Food and Drug Administration (FDA) is warning the

FDA Drug Safety Communication: Anti-seizure drug Potiga (ezogabine) linked to retinal abnormalities and blue skin discoloration Safety Announcement[removed]The U.S. Food and Drug Administration (FDA) is warning the

Add to Reading List

Source URL: www.fda.gov

Language: English
58Microsoft Word - for PDF   I  eng  pmappi_mpanni_2014-eng.docx

Microsoft Word - for PDF I eng pmappi_mpanni_2014-eng.docx

Add to Reading List

Source URL: www.hc-sc.gc.ca

Language: English - Date: 2014-04-08 09:52:11
59Health / Adverse effect / Clinical trial / Methadone / Adverse drug reaction / Package insert / Adverse effects of fluoroquinolones / Pharmacology / Pharmaceutical sciences / Medicine

DOC Document

Add to Reading List

Source URL: www.hc-sc.gc.ca

Language: English - Date: 2014-04-08 09:53:15
60Microsoft Word - for PDF   H  eng  pmapph_mpannh_2014-eng.docx

Microsoft Word - for PDF H eng pmapph_mpannh_2014-eng.docx

Add to Reading List

Source URL: www.hc-sc.gc.ca

Language: English - Date: 2014-04-08 09:52:11